Medimaging Integrated Solution (TPE:6796) ROCE %: -3.16% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:6796 Medimaging Integrated Solution Inc TPE:6796
80 GF Score
Price NT$65.30
GF Value NT$104.01
Valuation Possible Value Trap
! 9 Warning Signs
View Full Analysis

What is Medimaging Integrated Solution ROCE %?

Medimaging Integrated Solution TPE:6796 +4.48% 80 ROCE % is -3.16% as of Mar. 2026. GuruFocus rates TPE:6796 with a GF Score™ of 80/100 and a GF Value™ of NT$104.01 (Possible Value Trap). The stock has 9 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Medimaging Integrated Solution's annualized ROCE % for the quarter that ended in Mar. 2026 was -3.16%.

Medimaging Integrated Solution  (TPE:6796) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Medimaging Integrated Solution ROCE % Related Terms

Medimaging Integrated Solution ROCE % Historical Data

* Premium members only.

The historical data trend for Medimaging Integrated Solution's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medimaging Integrated Solution ROCE % Chart

Medimaging Integrated Solution Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial 15.85 13.92 10.21 1.80 2.31

Medimaging Integrated Solution Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.96 -12.03 2.63 17.78 -3.16
TPE:6796
80GF Score
Medimaging Integrated Solution Inc TPE:6796
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medimaging Integrated Solution ROCE % Calculation

Medimaging Integrated Solution's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=26.037/( ( (1356.136 - 215.6) + (1571.704 - 455.263) )/ 2 )
=26.037/( (1140.536+1116.441)/ 2 )
=26.037/1128.4885
=2.31 %

Medimaging Integrated Solution's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-37.212/( ( (1571.704 - 455.263) + (1677.327 - 439.289) )/ 2 )
=-37.212/( ( 1116.441 + 1238.038 )/ 2 )
=-37.212/1177.2395
=-3.16 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -3.16% mean?
Medimaging Integrated Solution (TPE:6796) has a ROCE % of -3.16% as of Mar. 2026.
Is Medimaging Integrated Solution's ROCE % too high?
Medimaging Integrated Solution's current ROCE % is -3.16%. Overall, Medimaging Integrated Solution has a GF Score™ of 80/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Medimaging Integrated Solution's ROCE % compare to ABT and SYK?
Medimaging Integrated Solution's ROCE % of -3.16% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.97. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.97, based on 811 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medimaging Integrated Solution's current ROCE % is -3.16%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medimaging Integrated Solution stock overvalued right now?
Based on GuruFocus' analysis, Medimaging Integrated Solution (TPE:6796) is currently considered Possible Value Trap. The stock's GF Value™ is NT$104.01, compared to a current price of NT$65.30 — trading 37.2% below its estimated fair value. The current ROCE % is -3.16%. Medimaging Integrated Solution's overall GF Score™ is 80/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Medimaging Integrated Solution (TPE:6796), the current ROCE % is -3.16% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medimaging Integrated Solution (TPE:6796) Overvalued in 2026?

Based on GuruFocus' analysis, Medimaging Integrated Solution stock appears to be undervalued. The current stock price of NT$65.30 is trading 37.2% below its estimated GF Value™ of NT$104.01. GuruFocus considers Medimaging Integrated Solution to be Possible Value Trap.

Key valuation signals for TPE:6796:

  • ROCE %: -3.16%
  • GF Value™: NT$104.01 vs. price of NT$65.30 (37.2% below fair value)
  • GF Score™: 80/100 with 9 warning signs

No single metric tells the full story. See the TPE:6796 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medimaging Integrated Solution Business Description

Address No.24-2, Industry E. Road IV, 3rd Floor, Hsinchu Science Park, Hsinchu, TWN, 30077
Medimaging Integrated Solution Inc and its subsidiaries are engaged in the design, manufacturing, and sales of digital medical imaging diagnostic equipment and related products and services. The company is a trusted partner of hospitals, medical schools, and health organizations, providing practitioners with digital and portable diagnostic solutions. The company designs and manufactures digital hand-held diagnostic scopes. Its products include Horus Scope, Smart Solutions, Endoscopy, and Micro Camera Modules.
80GF Score

Get the complete analysis for TPE:6796

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$65.30
Price
NT$104.01
GF Value